From Neuroscience News: Complete Post through this link…
Summary: A new study paves the way for potential treatments for Multiple Sclerosis (MS) by identifying the OTC antihistamine, clemastine, as an effective drug for brain repair. Utilizing a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on brain myelin levels.
The study offers the first documented example of brain repair for a chronic neurological condition through MRI. These results are expected to set a standard for future research into myelin-rebuilding therapies.
- Clemastine, an over-the-counter antihistamine, has been identified as a potential therapy for MS, with observed increases in myelin water fraction indicating myelin repair.
- A unique MRI technique was used to measure changes in myelin levels before and after the drug was administered, setting a new standard for tracking myelin recovery.
- Beyond its potential impact on MS, clemastine is also being considered for use in treating brain injury in premature infants, who often experience myelin damage.